Klinické štúdie Depresia v štáte Washington
21 štúdií pre Depresia hľadá účastníkov v zariadeniach v štáte Washington.
Mestá v štáte Washington
Oficiálny text štúdie (anglicky)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07775300A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
Prebieha náborFáza 3
Vek 18 až 85 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06793397RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Seattle Neuropsychiatric Treatment Center, Seattle
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07065240PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Seattle NTC, Seattle
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06713616A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT07226232A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
Prebieha náborFáza 3
Vek 18 až 50 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06775379A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Core Clinical Research /ID# 226374, Everett
Prebieha náborFáza 3
Vek 10 až 17 · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 7. 2026 · NCT06966401CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
- Madigan Army Medical Center, Fort Lewis
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 7. 2026 · NCT05663034TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Seattle Children's Hospital, Seattle
Prebieha náborObservačná štúdia
18 Months – 11 Years · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT07048574A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Center For Anxiety and Depression, Mercer Island
- Seattle Neuropsychiatric Treatment Center, Seattle
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 11. 5. 2026 · NCT06524830Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Seattle Children's Hospital, Seattle
Prebieha nábor
Vek 12 až 22 · Všetky pohlavia · Aktualizované 30. 10. 2025 · NCT06232304Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 10. 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
Prebieha náborFáza 4
Vek 18 až 65 · Všetky pohlavia · Aktualizované 23. 1. 2025 · NCT06223880Lay-Delivered Behavioral Activation in Senior Centers
- Enumclaw Senior Center, Enumclaw
- Casa Latina, Seattle
- Centro de la Raza, Seattle
- a 1 ďalších
Prebieha nábor
Vek 60 a viac · Všetky pohlavia · Aktualizované 15. 10. 2024 · NCT04621877Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.